Related content

The effect of 1-year transdermal estrogen replacement therapy on bone mineral density and biochemical markers of bone turnover in osteopenic postmenopausal systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial

By Bhattoa H.   Bettembuk P.   Balogh A.   Szegedi G.   Kiss E.  

Osteoporosis International, Vol. 15, Iss. 5, 2004-05 ,pp. : 396-404

Springer Publishing Company

Access to resources Recommend Favorite

Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial

By Lems W.   Lodder M.   Lips P.   Bijlsma J.   Geusens P.   Schrameijer N.   Ven C.   Dijkmans B.  

Osteoporosis International, Vol. 17, Iss. 5, 2006-05 ,pp. : 716-723

Springer Publishing Company

Access to resources Recommend Favorite

The Protective Effect of Zoledronic Acid on Bone Loss in Postmenopausal Women with Early Breast Cancer Treated with Sequential Tamoxifen and Letrozole: A Prospective, Randomized, Phase II Trial

By  

Oncology, Vol. 81, Iss. 5-6, 2011-12 ,pp. : 298-305

Karger

Access to resources Recommend Favorite

5‐year follow‐up of a randomized controlled trial of immediate versus delayed zoledronic acid for the prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen: N03CC (Alliance) trial

By  

CANCER, Vol. 121, Iss. 15, 2015-08 ,pp. : 2537-2543

John Wiley & Sons Inc

Access to resources Recommend Favorite

Randomized controlled trial of the effect of hysterectomy or LNG-IUS use on bone mineral density: a five-year follow-up

By Halmesmääki Karoliina H   Paavonen Jorma A   Tuppurainen Marjo T   Hurskainen Ritva A  

Therapy, Vol. 3, Iss. 4, 2006-07 ,pp. : 509-515

Future Medicine

Access to resources Recommend Favorite